Immunology and Biotherapies
38.0K views | +1 today
Follow
Immunology and Biotherapies
Page Ressources et Actualités du DIU immunologie et biothérapies
Your new post is loading...
Your new post is loading...
Scooped by Gilbert C FAURE
Scoop.it!

Dose-Response Study of Ibalizumab (Monoclonal Antibody) Plus Optimized Background Regimen in Patients With HIV-1

Dose-Response Study of Ibalizumab (Monoclonal Antibody) Plus Optimized Background Regimen in Patients With HIV-1 | Immunology and Biotherapies | Scoop.it
From nonamos.com - February 3, 2013 8:23 AM
The investigational product, ibalizumab, is a humanized IgG4 monoclonal antibody administered via intravenous infusion at 800 mg every 2 weeks or at 2000 m...
more...
No comment yet.
Sign up to comment
Scooped by Gilbert C FAURE
Scoop.it!

Anti-CD4 Monoclonal Antibody Ibalizumab Exhibits Breadth and ...

Anti-CD4 Monoclonal Antibody Ibalizumab Exhibits Breadth and ... | Immunology and Biotherapies | Scoop.it
From www.globalhealthhub.org - December 22, 2012 4:00 AM
Keeping up with global health & development news, blogosphere, journals, forums, events, jobs and more.
more...
No comment yet.
Sign up to comment
Scooped by Gilbert C FAURE
Scoop.it!

Anti-CD4 Monoclonal Antibody Ibalizumab Exhibits Breadth and... : JAIDS Journal of Acquired Immune Deficiency Syndromes

Anti-CD4 Monoclonal Antibody Ibalizumab Exhibits Breadth and... : JAIDS Journal of Acquired Immune Deficiency Syndromes | Immunology and Biotherapies | Scoop.it
From journals.lww.com (via @journalaids) - December 22, 2012 3:13 PM
Objectives: Passive immunization for the prevention of HIV-1 infection is currently being reenergized.
more...
No comment yet.
Sign up to comment
About Follow us Resources Terms Mobile Features
Facebook
X
LinkedIn